首页> 外文会议>Radteh Europe Conference and Exhibition >Real 3D Writing by Two Photon Induced Polymerization
【24h】

Real 3D Writing by Two Photon Induced Polymerization

机译:由两个光子诱导聚合的真实3D写入

获取原文

摘要

Photo induced polymerization is utilized in stereolithography and rapid prototyping to provide 3D structures with greatly improved resolution in comparison to melt based 3D printing. Traditional stereolithography tends to be limited, however, to the diffraction limit of the light used. Achieving even smaller features is possible, and two-photon induced photopolymerization (TPIP) is one of the more promising top-down approaches for doing this [1-3]. As the name implies, TPIP requires the absorption of two photons for an initiating molecule to be activated to induce polymerization. This necessitates an extremely high flux of light provided by a femtosecond- pulsed NIR laser. Since polymerization can occur only within the focus of the laser beam, resolution is about one order of magnitude better (line widths of about 100 nm) than μ- stereolithography. Fundamentally, the biggest advantage is that this level of control is afforded not just in the x-y plane but also along the z-axis, thus “real” 3D writing can be performed within a suitable matrix to provide cured 3D structures [4]. Interestingly, since water and hydrocarbons are virtually transparent in the NIR, it is possible to write through living tissue without causing damage [5]. The capabilities of TPIP are likely still not fully realized but already provide great promise in diverse fields such as microelectronics, μTAS, optical communications, and regenerative medicine [6,7].
机译:相对于熔融的3D印刷相比,光刻和快速原型化的光诱导的聚合用于提供三维结构,该分辨率大大提高了分辨率。然而,传统的立体化倾向于有限地限制在所用光的衍射极限。实现甚至更小的特征,并且双光子诱导的光聚合(TPIP)是做这一点的最有前途的自上而下方法之一[1-3]。顾名思义,TPIP需要吸收两种光子,以便被激活以诱导聚合。这需要由飞秒脉冲的Nir激光器提供的极高通量。由于聚合可以仅发生在激光束的焦点内,因此分辨率大约是比μ立体光刻更好的大约一个数量级(线宽约100nm)。从根本上说,最大的优点是,这种控制水平不仅在X-Y平面中提供,而且沿着Z轴,因此可以在合适的矩阵内执行“真实”的3D写入以提供固化的3D结构[4]。有趣的是,由于水和碳氢化合物在NIR中几乎是透明的,因此可以通过活组织写入而不会导致损坏[5]。 TPIP的能力可能仍然没有完全实现,但已经在多种领域(如微电子,μTAS,光通信和再生药)提供了很大的承诺[6,7]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号